RSV can be dangerous for older adults. Help vaccine research.

Respiratory syncytial virus, or RSV, is a common and highly contagious virus that usually causes mild, cold-like symptoms. While many people recover in a week or two, the virus can be dangerous in older adults and infants.

RSV can cause serious illness in older adults, especially those with heart or lung diseases such as COPD, asthma, or heart failure; or weakened immune systems. As of now, there are no approved vaccines for RSV.

But researchers are working to change that. We’re looking for clinical trial volunteers age 60 and older to help test study vaccines for RSV that aren’t available from your regular doctor.

What are clinical trials?

Clinical trials are medical research studies that test investigational drugs and treatments.

People may not give much thought to clinical research, but everything from aspirin to chemotherapy has been carefully tested before being prescribed by your doctor.

Clinical trials need human volunteers, who participate under the supervision of a doctor and/or health professionals. As the trial goes on, the doctors gather more and more information about the drug or treatment under investigation. It is only through clinical trials that we learn if drugs and treatments are both effective and safe.

Just takes a few minutes

Get started now

COVID-19 update — we remain open.

For the safety of both staff and participants, Synexus sites are COVID-19 SMART facilities. That means we use best practices to reduce virus exposure and are dedicated to ensuring we remain open and available for the research of investigational medications.

COVID-19 SMART steps we are taking to ensure safety include:

  • Greatly increased availability of video office visits
  • Ensuring social distancing measures are taken in all waiting areas
  • Continuing the practice of cleaning and disinfecting exam rooms thoroughly between every participant visit
  • Appropriate personal protective equipment (PPE) for all staff members at our health clinics

Take the next step to see if you qualify for local clinical trials of RSV vaccines.

Get started now

Dedicated to conducting clinical trials, Synexus have been investigating the effectiveness of new medicines and treatments for more than 25 years. We have vast experience in conducting clinical research with over 180 sites around the world. Each has its own dedicated team of highly trained doctors and nurses to provide our patients with the highest level of comfort and professionalism.

More about Synexus

Respiratory Syncytial Virus (RSV) - Synexus